Respicio G

Improvement in Psoriasis During Rituximab Therapy for Mixed Cryoglobulinemia Type II

Publish date: September 1, 2010

Rituximab is a B-cell depleting monoclonal antibody targeting CD20. Data concerning the behavior of psoriatic disease following rituximab therapy ...